All In Biotech

Drug Trial Radar · NCT02015520

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

A Phase IIb, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Evaluate the Efficacy and Safety of Clazakizumab in Subjects With Moderate to Severe Active Rheumatoid Arthritis Who Have Experienced an Inadequate Response to TNF Inhibitors

Last checked: Nov 20, 2026Latest source record: May 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 143 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

143

Actual

Start

Jun 2012

Primary completion

Jun 2013

Study completion Jun 2015

Sponsor

Lead sponsor
CSL BehringIndustry
Sponsor type
Industry
First posted
Dec 19, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to identify an appropriate dose of study medication.

Conditions

  • Rheumatoid Arthritis

Interventions

  • ClazakizumabDrug

  • Placebo (Matching with Clazakizumab)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Disease Activity Score in 28 Joints - C-reactive Protein (DAS28-CRP) at Week 12Time frame: Baseline and Week 12

Locations

55 sites in 9 countries. Site status is shown where the registry gives one.

  • Rheumatology Associates Of North Alabama, P.C.

    Huntsville, Alabama

  • Mercy Clinic Hot Springs Communities

    Hot Springs, Arkansas

  • Valerius Med Group & Res Ctr Of Greater Long Beach, Inc.

    Long Beach, California

  • Desert Medical Advances

    Palm Desert, California

  • Sarasota Arthritis Research Center

    Sarasota, Florida

  • Clinical Pharmacology Study Group

    Worcester, Massachusetts

  • St. Paul Rheumatology, P.A.

    Eagan, Minnesota

  • Physician Research Collaboration, Llc

    Lincoln, Nebraska

  • Albuquerque Center For Rheumatology

    Albuquerque, New Mexico

  • Albuquerque Clinical Trials

    Albuquerque, New Mexico

  • Joint And Muscle Medical Care And Research Institute (Jmmcri)

    Charlotte, North Carolina

  • Physicians East, Pa

    Greenville, North Carolina

  • Cincinnati Rheumatic Disease Study Group

    Cincinnati, Ohio

  • Paramount Medical Research & Consulting, Llc

    Middleburg Heights, Ohio

  • Arthritis & Rheumatology Center Of Oklahoma Pllc

    Oklahoma City, Oklahoma

  • Health Research Of Oklahoma

    Oklahoma City, Oklahoma

  • Healthcare Research Consultants

    Tulsa, Oklahoma

  • Low Country Rheumatology

    Charleston, South Carolina

  • Rheumatology Consultants Pllc

    Knoxville, Tennessee

  • Center For Inflammatory Disease

    Nashville, Tennessee

  • Seattle Rheumatology Associates

    Seattle, Washington

  • Local Institution

    Buenos Aires, Argentina

  • Local Institution

    Buenos Aires, Argentina

  • Local Institution

    Córdoba, Argentina

  • Local Institution

    San Miguel de Tucumán, Argentina

  • Local Institution

    Quilmes, Buenos Aires, Argentina

  • Cividino Medicine Professional Corporation

    Hamilton, Ontario, Canada

  • Credit Valley Rheumatology

    Mississauga, Ontario, Canada

  • Dr. Latha Naik Medical Professional Corporation

    Saskatoon, Saskatchewan, Canada

  • Local Institution

    Bordeaux, France

  • Local Institution

    Paris, France

  • Local Institution

    Poitiers, France

  • Local Institution

    Budapest, Hungary

  • Local Institution

    Debrecen, Hungary

  • Local Institution

    Veszprém, Hungary

  • Local Institution

    Catanzaro, Italy

  • Local Institution

    Florence, Italy

  • Local Institution

    Naples, Italy

  • Local Institution

    Pisa, Italy

  • Local Institution

    Chiba, Chiba, Japan

Showing 40 of 55 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.